Neurocrine Biosciences, Inc.

Organization

San Diego, CA, US

Ticker Symbols

NASDAQ:NBIX

BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES)
Business Address
12780 EL CAMINO REAL SAN DIEGO CA 92130 (858) 617-7600
Mailing Address
12780 EL CAMINO REAL SAN DIEGO CA 92130
State Location
CA
State of Incorporation
CA

Organizations

Please log in for detailed analytics

Patents Grantslast 30 patents

Information Patent Grant
Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methyl...
- Patent number 12,128,033
- Issue date Oct 29, 2024
- Neurocrine Biosciences, Inc.
- Andrew Becker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Pharmaceutical formulations for treating endometriosis, uterine fib...
- Patent number 12,102,637
- Issue date Oct 1, 2024
- AbbVie Inc.
- Jayanthy Jayanth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Solid pharmaceutical formulations for treating endometriosis, uteri...
- Patent number 12,083,227
- Issue date Sep 10, 2024
- AbbVie Inc.
- Yihong Qiu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of congenital adrenal hyperplasia
- Patent number 11,730,739
- Issue date Aug 22, 2023
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors
- Patent number 11,718,618
- Issue date Aug 8, 2023
- Neurocrine Biosciences, Inc.
- Nicole Harriott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Gonadotropin-releasing hormone receptor antagonists and methods rel...
- Patent number 11,713,324
- Issue date Aug 1, 2023
- Neurocrine Biosciences, Inc.
- Graham Beaton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 11,654,142
- Issue date May 23, 2023
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Processes for the preparation of uracil derivatives
- Patent number 11,459,305
- Issue date Oct 4, 2022
- Neurocrine Biosciences, Inc.
- Donald J. Gallagher
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 11,439,629
- Issue date Sep 13, 2022
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Treatment of congenital adrenal hyperplasia
- Patent number 11,311,544
- Issue date Apr 26, 2022
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High dosage valbenazine formulation and compositions, methods, and...
- Patent number 11,311,532
- Issue date Apr 26, 2022
- Neurocrine Biosciences, Inc.
- Richard Alexander Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11BH-pyrido-[2...
- Patent number 11,053,242
- Issue date Jul 6, 2021
- Neurocrine Biosciences, Inc.
- Neil Ashweek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
VMAT2 inhibitor compounds and compositions thereof
- Patent number 11,040,970
- Issue date Jun 22, 2021
- Neurocrine Biosciences, Inc.
- Nicole Harriott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 11,040,029
- Issue date Jun 22, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and...
- Patent number 11,033,539
- Issue date Jun 15, 2021
- Neurocrine Biosciences, Inc.
- Nicole Harriott
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 11,026,931
- Issue date Jun 8, 2021
- Neurocrine Biosciences, Inc.
- Grace S. Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
High dosage valbenazine formulation and compositions, methods, and...
- Patent number 11,026,939
- Issue date Jun 8, 2021
- Neurocrine Biosciences, Inc.
- Richard Alexander Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Substituted triazoles and methods relating thereto
- Patent number 11,021,449
- Issue date Jun 1, 2021
- Neurocrine Biosciences, Inc.
- Neil J. Ashweek
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,993,941
- Issue date May 4, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,952,997
- Issue date Mar 23, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Gonadotropin-releasing hormone receptor antagonists and methods rel...
- Patent number 10,941,159
- Issue date Mar 9, 2021
- Neurocrine Biosciences, Inc.
- Graham Beaton
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,940,141
- Issue date Mar 9, 2021
- Neurocrine Biosciences, Inc.
- Gordon Raphael Loewen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,...
- Patent number 10,919,892
- Issue date Feb 16, 2021
- Neurocrine Biosciences, Inc.
- Kevin McGee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,912,771
- Issue date Feb 9, 2021
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,...
- Patent number 10,906,903
- Issue date Feb 2, 2021
- Neurocrine Biosciences, Inc.
- Kevin McGee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Treatment of congenital adrenal hyperplasia
- Patent number 10,905,690
- Issue date Feb 2, 2021
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,...
- Patent number 10,906,902
- Issue date Feb 2, 2021
- Neurocrine Biosciences, Inc.
- Kevin McGee
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,874,648
- Issue date Dec 29, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,857,148
- Issue date Dec 8, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Methods for the administration of certain VMAT2 inhibitors
- Patent number 10,857,137
- Issue date Dec 8, 2020
- Neurocrine Biosciences, Inc.
- Christopher F. O'Brien
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Patents Applicationslast 30 patents

Information Patent Application
VALBENAZINE COMPOSITIONS
- Publication number 20250000805
- Publication date Jan 2, 2025
- Neurocrine Biosciences, Inc.
- Richard Alexander Moore
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PHARMACEUTICAL FORMULATIONS FOR TREATING ENDOMETRIOSIS, UTERINE FIB...
- Publication number 20250000862
- Publication date Jan 2, 2025
- ABBVIE INC.
- Jayanthy Jayanth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VALBENAZINE FOR USE IN THE TREATMENT OF DYSKINESIA DUE TO CEREBRAL...
- Publication number 20240342160
- Publication date Oct 17, 2024
- Neurocrine Biosciences, Inc.
- Grace S. Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
VALBENAZINE FOR USE IN THE ADD-ON TREATMENT OF SCHIZOPHRENIA
- Publication number 20240342159
- Publication date Oct 17, 2024
- Neurocrine Biosciences, Inc.
- Angel S. Angelov
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE SYNTHESIS OF VALBENAZINE
- Publication number 20240239791
- Publication date Jul 18, 2024
- Neurocrine Biosciences, Inc.
- John Lloyd Tucker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYL...
- Publication number 20240238257
- Publication date Jul 18, 2024
- Neurocrine Biosciences, Inc.
- Andrew Becker
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE COMBINED ADMINISTRATION OF DEUTETRABENAZINE AND A C...
- Publication number 20240207247
- Publication date Jun 27, 2024
- Neurocrine Biosciences, Inc.
- Gordon Loewen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GPR52 MODULATORS AND METHODS OF USE
- Publication number 20240208907
- Publication date Jun 27, 2024
- Neurocrine Biosciences, Inc.
- Juan Pablo Cueva-Garcia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS
- Publication number 20240197714
- Publication date Jun 20, 2024
- Neurocrine Biosciences, Inc.
- Gordon Loewen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
- Publication number 20240058342
- Publication date Feb 22, 2024
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRF RECEPTOR ANTAGONISTS AND METHODS OF USE
- Publication number 20240024330
- Publication date Jan 25, 2024
- Neurocrine Biosciences, Inc.
- Gordon Raphael Loewen
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SUBSTITUTED PYRIDO[2,1-a]ISOQUINOLINES AS VMAT2 INHIBITORS
- Publication number 20240010647
- Publication date Jan 11, 2024
- Neurocrine Biosciences, Inc.
- Nicole Harriott
- C07 - ORGANIC CHEMISTRY
Information Patent Application
SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYL...
- Publication number 20230286932
- Publication date Sep 14, 2023
- Neurocrine Biosciences, Inc.
- Andrew PALMER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
PHARMACEUTICAL FORMULATIONS FOR TREATING ENDOMETRIOSIS, UTERINE FIB...
- Publication number 20230255968
- Publication date Aug 17, 2023
- ABBVIE INC.
- Jayanthy Jayanth
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRF1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF CONGENITAL ADRENAL HY...
- Publication number 20230255942
- Publication date Aug 17, 2023
- Neurocrine Biosciences, Inc.
- Robert H. Farber
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYL...
- Publication number 20230233534
- Publication date Jul 27, 2023
- Neurocrine Biosciences, Inc.
- Andrew Palmer
- C07 - ORGANIC CHEMISTRY
Information Patent Application
GPR52 MODULATORS AND METHODS OF USE
- Publication number 20230234925
- Publication date Jul 27, 2023
- Neurocrine Biosciences, Inc.
- Juan Pablo Cueva-Garcia
- C07 - ORGANIC CHEMISTRY
Information Patent Application
VMAT2 INHIBITORS AND METHODS OF USE
- Publication number 20230159528
- Publication date May 25, 2023
- Neurocrine Biosciences, Inc.
- Nicole Harriott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE
- Publication number 20230129359
- Publication date Apr 27, 2023
- Neurocrine Biosciences, Inc.
- Nicole Harriott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRF RECEPTOR ANTAGONISTS AND METHODS OF USE
- Publication number 20230065034
- Publication date Mar 2, 2023
- Neurocrine Biosciences, Inc.
- Neil J. ASHWEEK
- G01 - MEASURING TESTING
Information Patent Application
MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE
- Publication number 20230046329
- Publication date Feb 16, 2023
- Neurocrine Biosciences, Inc.
- Nicholas Pagano
- C07 - ORGANIC CHEMISTRY
Information Patent Application
CRF RECEPTOR ANTAGONISTS AND METHODS OF USE
- Publication number 20220409592
- Publication date Dec 29, 2022
- Neurocrine Biosciences, Inc.
- Evan SMITH
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
PROCESSES FOR THE SYNTHESIS OF VALBENAZINE
- Publication number 20220363680
- Publication date Nov 17, 2022
- Neurocrine Biosciences, Inc.
- John TUCKER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Methods for the Administration of Certain VMAT2 Inhibitors
- Publication number 20220040169
- Publication date Feb 10, 2022
- Neurocrine Biosciences, Inc.
- Grace S. Liang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CRF1 RECEPTOR ANTAGONIST, PHARMACEUTICAL FORMULATIONS AND SOLID FOR...
- Publication number 20220023266
- Publication date Jan 27, 2022
- Neurocrine Biosciences, Inc.
- Robert H. FARBER
- C07 - ORGANIC CHEMISTRY
Information Patent Application
TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA
- Publication number 20210361659
- Publication date Nov 25, 2021
- Neurocrine Biosciences, Inc.
- Dimitri E. Grigoriadis
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
N-[2-(1 -BENZYLPIPERIDIN-4-YL)ETHYL]-4-(PYRAZIN-2-YL)-PIPERAZINE-1...
- Publication number 20210338653
- Publication date Nov 4, 2021
- Neurocrine Biosciences, Inc.
- Nicole Harriott
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS
- Publication number 20210338651
- Publication date Nov 4, 2021
- Neurocrine Biosciences, Inc.
- Gordon LOEWEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS REL...
- Publication number 20210284653
- Publication date Sep 16, 2021
- Neurocrine Biosciences, Inc.
- Graham Beaton
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS
- Publication number 20210220345
- Publication date Jul 22, 2021
- Neurocrine Biosciences, Inc.
- Gordon LOEWEN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Trademarklast 30 trademarks

Information Trademark
99025787 - CRENESSITY
- Serial number 99025787
- Filing date Jan 31, 2025
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99021849 - CRENESSITY
- Serial number 99021849
- Filing date Jan 29, 2025
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99021870 - CRENESSITY
- Serial number 99021870
- Filing date Jan 29, 2025
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99021883 - CRENESSITY
- Serial number 99021883
- Filing date Jan 29, 2025
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99021889 - CRENESSITY
- Serial number 99021889
- Filing date Jan 29, 2025
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
99021893 - CRENESSITY
- Serial number 99021893
- Filing date Jan 29, 2025
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98927796 - AMPA-NOVA
- Serial number 98927796
- Filing date Dec 30, 2024
- Neurocrine Biosciences, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
98927799 - AMPA-VEGA
- Serial number 98927799
- Filing date Dec 30, 2024
- Neurocrine Biosciences, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
98927803 - AMPA-SIRIUS
- Serial number 98927803
- Filing date Dec 30, 2024
- Neurocrine Biosciences, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
98908360 - CRENESSIFRIENDS
- Serial number 98908360
- Filing date Dec 17, 2024
- Neurocrine Biosciences, Inc.
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
Information Trademark
98908406 - CRINECERFRIENDS
- Serial number 98908406
- Filing date Dec 17, 2024
- Neurocrine Biosciences, Inc.
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
Information Trademark
98627503
- Serial number 98627503
- Filing date Jul 1, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98621733 - CAHTALOG
- Serial number 98621733
- Filing date Jun 27, 2024
- Neurocrine Biosciences, Inc.
- 9 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments
Information Trademark
98438563 - TAKING ON TD
- Serial number 98438563
- Filing date Mar 7, 2024
- Neurocrine Biosciences, Inc.
- 35 - Advertising
Information Trademark
98432378 - MORE THAN HD
- Serial number 98432378
- Filing date Mar 4, 2024
- Neurocrine Biosciences, Inc.
- 35 - Advertising
Information Trademark
98421458 - WHAT THE C@H?!
- Serial number 98421458
- Filing date Feb 26, 2024
- Neurocrine Biosciences, Inc.
- 35 - Advertising
Information Trademark
98421393 - WHAT THE C@H?!
- Serial number 98421393
- Filing date Feb 26, 2024
- Neurocrine Biosciences, Inc.
- 35 - Advertising
Information Trademark
98421438 - WTC@H?!
- Serial number 98421438
- Filing date Feb 26, 2024
- Neurocrine Biosciences, Inc.
- 35 - Advertising
Information Trademark
98404850
- Serial number 98404850
- Filing date Feb 14, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98404839
- Serial number 98404839
- Filing date Feb 14, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98404854 - CRENESSITY
- Serial number 98404854
- Filing date Feb 14, 2024
- Neurocrine Biosciences, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
98365357 - CANECT-HD
- Serial number 98365357
- Filing date Jan 19, 2024
- Neurocrine Biosciences, Inc.
- 42 - Scientific and technological services and research and design relating thereto
Information Trademark
98360616
- Serial number 98360616
- Filing date Jan 17, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98360609
- Serial number 98360609
- Filing date Jan 17, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98361283
- Serial number 98361283
- Filing date Jan 17, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98354441
- Serial number 98354441
- Filing date Jan 12, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98354457
- Serial number 98354457
- Filing date Jan 12, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98354497
- Serial number 98354497
- Filing date Jan 12, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98354380
- Serial number 98354380
- Filing date Jan 12, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations
Information Trademark
98354390
- Serial number 98354390
- Filing date Jan 12, 2024
- Neurocrine Biosciences, Inc.
- 5 - Pharmaceutical and veterinary preparations

Neurocrine Biosciences, Inc.

Organization

Ticker Symbols

Business Address

Mailing Address

State Location

State of Incorporation

Patents Grantslast 30 patents

Synthetic methods for preparation of 4-(2-chloro-4-methoxy-5-methyl...

Pharmaceutical formulations for treating endometriosis, uterine fib...

Solid pharmaceutical formulations for treating endometriosis, uteri...

Treatment of congenital adrenal hyperplasia

Substituted pyrido[2,1-a]isoquinolines as VMAT2 inhibitors

Gonadotropin-releasing hormone receptor antagonists and methods rel...

Methods for the administration of certain VMAT2 inhibitors

Processes for the preparation of uracil derivatives

Methods for the administration of certain VMAT2 inhibitors

Treatment of congenital adrenal hyperplasia

High dosage valbenazine formulation and compositions, methods, and...

[9,10-dimethoxy-3-(2-methylpropyl)-1H,2H,3H,4H,6H,7H,11BH-pyrido-[2...

VMAT2 inhibitor compounds and compositions thereof

Methods for the administration of certain VMAT2 inhibitors

Compounds of formulas (VII), (VIII), (IX), (XI), (XII), (XIII), and...

Methods for the administration of certain VMAT2 inhibitors

High dosage valbenazine formulation and compositions, methods, and...

Substituted triazoles and methods relating thereto

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

Gonadotropin-releasing hormone receptor antagonists and methods rel...

Methods for the administration of certain VMAT2 inhibitors

Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,...

Methods for the administration of certain VMAT2 inhibitors

Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,...

Treatment of congenital adrenal hyperplasia

Synthetic methods for preparation of (S)-(2R,3R,11bR)-3-isobutyl-9,...

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

Methods for the administration of certain VMAT2 inhibitors

Patents Applicationslast 30 patents

VALBENAZINE COMPOSITIONS

PHARMACEUTICAL FORMULATIONS FOR TREATING ENDOMETRIOSIS, UTERINE FIB...

VALBENAZINE FOR USE IN THE TREATMENT OF DYSKINESIA DUE TO CEREBRAL...

VALBENAZINE FOR USE IN THE ADD-ON TREATMENT OF SCHIZOPHRENIA

PROCESSES FOR THE SYNTHESIS OF VALBENAZINE

SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYL...

METHODS FOR THE COMBINED ADMINISTRATION OF DEUTETRABENAZINE AND A C...

GPR52 MODULATORS AND METHODS OF USE

METHODS FOR THE ADMINISTRATION OF CERTAIN VMAT2 INHIBITORS

TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

CRF RECEPTOR ANTAGONISTS AND METHODS OF USE

SUBSTITUTED PYRIDO[2,1-a]ISOQUINOLINES AS VMAT2 INHIBITORS

SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYL...

PHARMACEUTICAL FORMULATIONS FOR TREATING ENDOMETRIOSIS, UTERINE FIB...

CRF1 RECEPTOR ANTAGONIST FOR THE TREATMENT OF CONGENITAL ADRENAL HY...

SYNTHETIC METHODS FOR PREPARATION OF 4-(2-CHLORO-4-METHOXY-5-METHYL...

GPR52 MODULATORS AND METHODS OF USE

VMAT2 INHIBITORS AND METHODS OF USE

MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE

CRF RECEPTOR ANTAGONISTS AND METHODS OF USE

MUSCARINIC RECEPTOR 4 ANTAGONISTS AND METHODS OF USE

CRF RECEPTOR ANTAGONISTS AND METHODS OF USE

PROCESSES FOR THE SYNTHESIS OF VALBENAZINE

Methods for the Administration of Certain VMAT2 Inhibitors

CRF1 RECEPTOR ANTAGONIST, PHARMACEUTICAL FORMULATIONS AND SOLID FOR...

TREATMENT OF CONGENITAL ADRENAL HYPERPLASIA

N-[2-(1 -BENZYLPIPERIDIN-4-YL)ETHYL]-4-(PYRAZIN-2-YL)-PIPERAZINE-1...

METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS

GONADOTROPIN-RELEASING HORMONE RECEPTOR ANTAGONISTS AND METHODS REL...

METHODS FOR THE ADMINISTRATION OF COMT INHIBITORS

Trademarklast 30 trademarks

99025787 - CRENESSITY

99021849 - CRENESSITY

99021870 - CRENESSITY

99021883 - CRENESSITY

99021889 - CRENESSITY

99021893 - CRENESSITY

98927796 - AMPA-NOVA

98927799 - AMPA-VEGA

98927803 - AMPA-SIRIUS

98908360 - CRENESSIFRIENDS